Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
Open Access
- 1 October 1995
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 346 (8982), 1056-1059
- https://doi.org/10.1016/s0140-6736(95)91740-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Natural history and prognosis of variceal bleedingBailliere's Clinical Gastroenterology, 1992
- Definitions, methodology and therapeutic strategies in portal hypertension: A consensus development workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990Journal of Hepatology, 1992
- Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosisThe Lancet, 1991
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesNew England Journal of Medicine, 1991
- Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trialHepatology, 1991
- Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertensionHepatology, 1991
- Meta-analysis of value of propranolol in prevention of variceal haemorrhageThe Lancet, 1990
- Short-term effects of propranolol on portal venous pressureHepatology, 1986
- Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in CirrhosisHepatology, 1984
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981